Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection
PLoS One. 2015 Oct 9;10(10):e0140623.
doi: 10.1371/journal.pone.0140623.
eCollection 2015.